Efficacy testing of intralytix bacteriophage cocktail with in vitro activity against y. Pestis, in RAT plague model
Ended Awarded Last action
- Contract number
- 75N93022F00004
- Awardee
-
University Of Texas Medical Branch At Galveston UEI MSPWVMXXMN76 Part of University Of Texas System
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $513,687
Award facts
- Contract value 100% obligated
- $513,687.07 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Galveston, TX 77555, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$146,387 | |
| Original award | $660,074 |
About this award
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the University of Texas Medical Branch at Galveston (UTMB). The $513,687.07 delivery order falls under NIAID's larger $146.3 million Indefinite Delivery Contract for Preclinical Models of Infectious Diseases, which allows the agency to efficiently acquire a range of research and development services from UTMB. This specific contract is for efficacy testing of an Intralytix bacteriophage cocktail with in vitro activity against Yersinia pestis, the causative agent of plague, using a rat plague model. UTMB, a state-controlled institution of higher learning with extensive experience in biomedical research and infectious disease studies, will perform this work at its facilities in Galveston, Texas. The contract does not have a small business set-aside designation.
Quick answers
Who was awarded contract 75N93022F00004?
75N93022F00004 was awarded to University Of Texas Medical Branch At Galveston by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on June 10, 2022.
How much is contract 75N93022F00004 worth?
The government has obligated $513,687 on 75N93022F00004.
Is contract 75N93022F00004 an order under another contract?
Yes. 75N93022F00004 is a delivery order under HHSN272201700040I, an indefinite delivery contract, on NIAID Preclinical Models of Infectious Diseases 2017-2024.
Was contract 75N93022F00004 competed?
The extent of competition for 75N93022F00004 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award